Patent Assignment
Reel/Frame 074849/0457
Grant of Security Interest
Recorded: 2026-02-18
Pages: 9
Assignor
EAGLE PHARMACEUTICALS, INC
Executed: 2026-02-03
Assignee
ANKURA TRUST COMPANY, LLC.
140 SHERMAN STREET, 4TH FLOOR, FAIRFIELD, CONNECTICUT, 06824
Covered Properties
(42)
Methods and Devices for Impeding Crawling Arthropods from Entering Enclosed and Semi-Enclosed Spaces
Patent:
6,912,815 →
Application:
10/010,533 →
Instant Printer, Printing Method for Use in the Instant Printer, and Electronic Still Camera Incorporated with Printer
Application:
11/103,483 →
Publication:
US 2005/0179731
Article for Safely Transporting Wine and Spirit Glass Bottles and the Like
Application:
11/844,783 →
Publication:
US 2008/0116101
Formulations of Bendamustine
Application:
18/910,904 →
Publication:
US 2025/0177356
Formulations of Bendamustine
Application:
19/229,424 →
Publication:
US 2025/0295637
Formulations of Bendamustine
Formulations of Bendamustine
Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration
Formulations of Bendamustine
Application:
19/318,808 →
Publication:
US 2026/0000767
Methods of Using Dantrolene to Treat Nerve Agent Exposure
Application:
17/540,878 →
Publication:
US 2022/0087980
Methods of Treating Coronavirus Infections
Application:
17/995,606 →
Publication:
US 2023/0143775
Methods of Treating Sars-Cov-2 Infections
Methods of Treating Severe Acute Respiratory Syndrome
Methods of Treating Viral Infections
Application:
17/995,608 →
Publication:
US 2023/0149364
Fulvestrant Formulations
Application:
19/235,248 →
Publication:
US 2025/0302966
Formulations of Bendamustine
Formulations of Bendamustine
Formulations of Bendamustine
Formulations of Bendamustine
Formulations of Bendamustine
Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration
Formulations of Bendamustine
Formulations of Bendamustine
Formulations of Bendamustine
Formulations of Bendamustine
Formulations of Bendamustine
Formulations of Bendamustine
Formulations of Bendamustine
Formulations of Bendamustine
Alcohol Free Formulation of Argatroban
Alcohol Free Formulation of Argatroban
Formulations of Daptomycin
Pharmaceutical Compositions Containing Pemetrexed Having Extended Storage Stability
Fulvestrant Formulations
Fulvestrant Formulations
Fulvestrant Formulations and Methods of Their Use
Pemetrexed Formulations
Pemetrexed Formulations
Fulvestrant Formulations and Methods of Their Use
Fulvestrant Formulations
Fulvestrant Formulations and Methods of Their Use
Vial with Collar Label
Patent:
676,572 →
Application:
29/403,209 →
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 7, 2001
From: ROBERTS, ERNEST H.
To: LINEGUARD, INC.
Reel/Frame 012383/0913 →
Assignment of Assignor's Interest
Mar 23, 2007
From: FUJIFILM HOLDINGS CORPORATION (FORMERLY FUJI PHOTO FILM CO., LTD.)
To: FUJIFILM CORPORATION
Reel/Frame 019094/0411 →
Assignment of Assignor's Interest
Aug 24, 2007
From: SNYDER, AARON L.
To: FROM THE SOURCE, LLC
Reel/Frame 019743/0598 →
Assignment of Assignor's Interest
Mar 9, 2011
From: PALEPU, NAGESH R.; BUXTON, PHILIP CHRISTOPHER
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 025923/0962 →
Assignment of Assignor's Interest
Apr 30, 2014
From: PALEPU, NAGESH R.; BUXTON, PHILIP CHRISTOPHER
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 032790/0596 →
Assignment of Assignor's Interest
Apr 30, 2014
From: SUNDARAM, SRIKANTH; TARRIFF, SCOTT L.
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 032791/0091 →
Assignment of Assignor's Interest
Feb 25, 2015
From: TARRIFF, SCOTT L.
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 035025/0435 →
License
May 22, 2015
From: EAGLE PHARMACEUTICALS, INC.
To: CEPHALON, INC.
Reel/Frame 035696/0856 →
Security Interest
Jan 26, 2017
From: EAGLE PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 041095/0554 →
Assignment of Assignor's Interest
Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061333/0426 →
Assignment of Assignor's Interest
Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061333/0382 →
Assignment of Assignor's Interest
Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061334/0239 →
Assignment of Assignor's Interest
Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061334/0274 →
Assignment of Assignor's Interest
Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061333/0643 →
Assignment of Assignor's Interest
Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061333/0704 →
Assignment of Assignor's Interest
Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061333/0234 →
Assignment of Assignor's Interest
Oct 6, 2022
From: HEPNER, ADRIAN
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061333/0199 →
Security Interest
Nov 1, 2022
From: EAGLE PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061615/0013 →
Security Interest
Oct 11, 2024
From: EAGLE PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 068873/0898 →
Release of Security Interest
Apr 1, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 070703/0524 →
Security Interest
May 14, 2025
From: EAGLE SUBI LLC, A DELAWARE CORPORATION
To: LSI FINANCING LLC
Reel/Frame 071275/0866 →
Assignment of Assignor's Interest
Jul 20, 2026
From: EAGLE PHARMACEUTICALS, INC.
To: COSETTE PHARMACEUTICALS, INC.
Reel/Frame 076014/0635 →